(CXT) Crane NXT - Overview
Stock: Payment Systems, Security Tech, Authentication, Automation Software
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.20% |
| Yield on Cost 5y | 2.53% |
| Yield CAGR 5y | -20.71% |
| Payout Consistency | 96.3% |
| Payout Ratio | 24.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.4% |
| Relative Tail Risk | -6.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.24 |
| Alpha | -30.12 |
| Character TTM | |
|---|---|
| Beta | 1.168 |
| Beta Downside | 1.149 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.05% |
| CAGR/Max DD | 0.34 |
Description: CXT Crane NXT January 11, 2026
Crane NXT Co. (NYSE:CXT) is an industrial-technology firm that secures, detects, and authenticates high-value assets through two operating segments: Crane Payment Innovations, which delivers electronic equipment, automation, processing systems, field-service tools, remote diagnostics, and productivity software; and Security & Authentication Technologies, which offers proprietary anti-counterfeiting and brand-protection solutions for banknotes, consumer goods, industrial products, and digital content across online marketplaces and government channels. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
In its most recent fiscal year, Crane NXT reported revenue of roughly $1.2 billion, up about 8 % year-over-year, driven by strong growth in electronic payment terminals and an expanding portfolio of authentication services for e-commerce platforms. Operating margins have hovered near 12 %, reflecting efficient scaling of its software-enabled service contracts. The business benefits from macro-level tailwinds such as the projected 10 % CAGR in global digital payments through 2026 and heightened regulatory scrutiny on counterfeit goods, which together fuel demand for both payment-processing hardware and secure-product verification technologies.
For a deeper quantitative view, you may want to explore ValueRay’s analyst dashboard for CXT’s valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 154.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.80 > 1.0 |
| NWC/Revenue: 10.18% < 20% (prev 12.06%; Δ -1.88% < -1%) |
| CFO/TA 0.07 > 3% & CFO 216.8m > Net Income 154.7m |
| Net Debt (910.3m) to EBITDA (336.7m): 2.70 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.0m) vs 12m ago 0.35% < -2% |
| Gross Margin: 43.20% > 18% (prev 0.45%; Δ 4275 % > 0.5%) |
| Asset Turnover: 59.26% > 50% (prev 59.93%; Δ -0.66% > 0%) |
| Interest Coverage Ratio: 4.35 > 6 (EBITDA TTM 336.7m / Interest Expense TTM 56.2m) |
Altman Z'' 1.55
| A: 0.06 (Total Current Assets 770.6m - Total Current Liabilities 609.9m) / Total Assets 2.92b |
| B: 0.12 (Retained Earnings 336.3m / Total Assets 2.92b) |
| C: 0.09 (EBIT TTM 244.7m / Avg Total Assets 2.66b) |
| D: 0.18 (Book Value of Equity 311.1m / Total Liabilities 1.71b) |
| Altman-Z'' Score: 1.55 = BB |
Beneish M -2.60
| DSRI: 1.41 (Receivables 358.9m/233.2m, Revenue 1.58b/1.44b) |
| GMI: 1.04 (GM 43.20% / 45.00%) |
| AQI: 1.01 (AQ_t 0.63 / AQ_t-1 0.62) |
| SGI: 1.09 (Revenue 1.58b / 1.44b) |
| TATA: -0.02 (NI 154.7m - CFO 216.8m) / TA 2.92b) |
| Beneish M-Score: -2.60 (Cap -4..+1) = A |
What is the price of CXT shares?
Over the past week, the price has changed by +10.95%, over one month by +12.37%, over three months by -8.36% and over the past year by -11.49%.
Is CXT a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CXT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.3 | 36.2% |
| Analysts Target Price | 76.3 | 36.2% |
| ValueRay Target Price | 57.4 | 2.4% |
CXT Fundamental Data Overview February 03, 2026
P/E Forward = 10.4275
P/S = 1.8373
P/B = 2.3974
Revenue TTM = 1.58b USD
EBIT TTM = 244.7m USD
EBITDA TTM = 336.7m USD
Long Term Debt = 834.3m USD (from longTermDebt, last quarter)
Short Term Debt = 261.0m USD (from shortTermDebt, last quarter)
Debt = 1.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 910.3m USD (from netDebt column, last quarter)
Enterprise Value = 3.81b USD (2.90b + Debt 1.10b - CCE 182.4m)
Interest Coverage Ratio = 4.35 (Ebit TTM 244.7m / Interest Expense TTM 56.2m)
EV/FCF = 22.10x (Enterprise Value 3.81b / FCF TTM 172.6m)
FCF Yield = 4.53% (FCF TTM 172.6m / Enterprise Value 3.81b)
FCF Margin = 10.93% (FCF TTM 172.6m / Revenue TTM 1.58b)
Net Margin = 9.80% (Net Income TTM 154.7m / Revenue TTM 1.58b)
Gross Margin = 43.20% ((Revenue TTM 1.58b - Cost of Revenue TTM 896.8m) / Revenue TTM)
Gross Margin QoQ = 43.27% (prev 41.74%)
Tobins Q-Ratio = 1.31 (Enterprise Value 3.81b / Total Assets 2.92b)
Interest Expense / Debt = 1.48% (Interest Expense 16.2m / Debt 1.10b)
Taxrate = 23.57% (15.7m / 66.6m)
NOPAT = 187.0m (EBIT 244.7m * (1 - 23.57%))
Current Ratio = 1.26 (Total Current Assets 770.6m / Total Current Liabilities 609.9m)
Debt / Equity = 0.90 (Debt 1.10b / totalStockholderEquity, last quarter 1.21b)
Debt / EBITDA = 2.70 (Net Debt 910.3m / EBITDA 336.7m)
Debt / FCF = 5.27 (Net Debt 910.3m / FCF TTM 172.6m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.81% (Net Income 154.7m / Total Assets 2.92b)
RoE = 13.57% (Net Income TTM 154.7m / Total Stockholder Equity 1.14b)
RoCE = 12.39% (EBIT 244.7m / Capital Employed (Equity 1.14b + L.T.Debt 834.3m))
RoIC = 8.98% (NOPAT 187.0m / Invested Capital 2.08b)
WACC = 7.73% (E(2.90b)/V(4.00b) * Re(10.22%) + D(1.10b)/V(4.00b) * Rd(1.48%) * (1-Tc(0.24)))
Discount Rate = 10.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.35%
[DCF Debug] Terminal Value 74.47% ; FCFF base≈168.3m ; Y1≈127.5m ; Y5≈77.4m
Fair Price DCF = 10.73 (EV 1.53b - Net Debt 910.3m = Equity 616.4m / Shares 57.4m; r=7.73% [WACC]; 5y FCF grow -28.77% → 2.90% )
EPS Correlation: -61.83 | EPS CAGR: 0.63% | SUE: 0.75 | # QB: 0
Revenue Correlation: -48.76 | Revenue CAGR: -15.18% | SUE: 1.57 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.88 | Chg30d=-0.028 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=4.50 | Chg30d=-0.020 | Revisions Net=-3 | Growth EPS=+11.1% | Growth Revenue=+6.7%